1. , . Pathology of the Uterine Cervix, Vagina and Vulva. Philadelphia, PA: WB Saunders; 1989.
2. The vascular lymphatic and neural anatomy of the cervix. In: , ed. The Cervix. London: WB Saunders; 1976.
3. The Cervix Uteri and Its Diseases. Philadelphia, PA: WB Saunders; 1961.
4. . The cervical epithelium from fetal age to adolescence. Obstet Gynecol 1976; 47: 536–539.
5. Basic morphology of the prepuberal and youthful cervix: topographic and histologic features. J Reprod Med 1976; 16: 221–230.
6. . Multinucleated stromal giant cells of the uterine cervix. Arch Pathol Lab Med 1985; 109: 200–202.
7. . Current use of the Papanicolaou class system in gynecologic cytology. Diagn Cytopathol 1988; 4: 169–176.
8. . The new Bethesda System for reporting results of smears of the uterine cervix. J Natl Cancer Inst 1990; 82: 988–991.
9. , , , et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114–2119.
10. The Bethesda System for reporting cervical/vaginal cytologic diagnosis: an overview. Int J Gynecol Pathol 1991; 10: 323–325.
11. , The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. Definitions, Criteria and Explanatory Notes for Terminology and Specimen Adequacy. New York, NY: Springer-Verlag; 1994.
12. , , , , . 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120–2129.
13. , , , et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197: 346–355.
14. , , , et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis 2012; 16: 205–242.
15. , , Clinicopathologic correlation of the unsatisfactory Papanicolaou smear. Cancer 1997; 81: 139–143.
16. , , , et al. Homogeneous sampling accounts for the increased diagnostic accuracy using the ThinPrep Processor. Am J Clin Pathol 1994; 101: 215–219.
17. , , Cervical smear adequacy: cellularity references were found to increase both interobserver agreement and unsatisfactory rate. Cytopathology 2009; 20: 161–168.
18. . Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice. J Natl Compr Canc Netw 2004; 2: 597–611.
19. , , . Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences. Diagn Cytopathol 2012; 41: 257–278.
20. , , , Reproducibility of cervicovaginal ThinPrep cellularity assessment. Diagn Cytopathol 2002; 26: 19–21.
21. , , , , . Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology. Acta Cytol 2003; 47: 605–610.
22. . Pap smear adequacy: is our understanding satisfactory . . . or limited? Diagn Cytopathol 2001; 24: 79–81.
23. , , , . Efficacy of cervical-smear collection devices: a systematic review and meta-analysis. Lancet 1999; 354: 1763–1770.
24. , , , Relationship between the diagnosis of epithelial abnormalities and the composition of cervical smears. Acta Cytol 1985; 29: 323–328.
25. , , , The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities. Cancer 1999; 87: 113–117.
26. , , , et al. Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears. Am J Clin Pathol 2001; 115: 851–855.
27. . Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status. Cancer 2001; 93: 237–240.
28. , , , et al. Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection. J Low Genit Tract Dis 2008; 12: 71–81.
29. , , , et al. The unsatisfactory ThinPrep(R) Pap Test: analysis of technical aspects, most common causes, and recommendations for improvement. Diagn Cytopathol 2013; 41: 588–594.
30. , , Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis. BMJ Open 2012; 2: e000847.
31. , , , , Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood. Cancer 2006; 108: 27–31.
32. , , Acetic acid recovery of gynecologic liquid-based samples of apparent low squamous cellularity. Acta Cytol 2006; 50: 136–140.
33. , , , , Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2000; 124: 203–211.
34. , , , . MR specimen adequacy. In: , , eds., The Bethesda System for Reporting Cervical Cytology, 2nd edn. New York, NY: Springer; 2004.
35. , , , , Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol 2002; 187: 137–144.
36. , , , et al. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol 1995; 173: 534–543.
37. , , . Lymphoma-like lesions of the lower female genital tract: a report of 16 cases. Int J Gynecol Pathol 1985; 4: 289–299.
38. , , , , . Florid reactive lymphoid hyperplasia (lymphoma-like lesion) of the uterine cervix. Ann Diagn Pathol 2012; 16: 21–28.
39. , , , et al. Florid reactive lymphoid hyperplasia of the lower female genital tract (lymphoma-like lesion): a benign condition that frequently harbors clonal immunoglobulin heavy chain gene rearrangements. Am J Surg Pathol 2010; 34: 161–168.
40. , , , et al. Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 2006; 193: 617–624.
41. , , Behcet’s disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med 1971; 75: 561–570.
42. , , , et al. Comparison of Digene hybrid capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol 2002; 40: 641–644.
43. , , , , Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol 2001; 39: 1751–1756.
44. , , , , Cervical ureaplasma urealyticum colonization: comparison of PCR and culture for its detection and association with preterm birth. Scand J Infect Dis 2002; 34: 35–40.
45. , , , et al. Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. J Obstet Gynaecol 2011; 31: 237–241.
46. , , , et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 2002; 101: 371–374.
47. , , , , . Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 2002; 43: 277–281.
48. , , , et al. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst 2010; 102: 1794–1804.
49. , , , et al. Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies. J Clin Microbiol 2002; 40: 584–587.
50. , , Herpes simplex virus-2 infection. An emerging disease? Infect Dis Clin North Am 1998; 12: 47–61.
51. , , , et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992; 326: 1533–1539.
52. , , , . Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population. J Clin Microbiol 2001; 39: 3321–3325.
53. . The changing epidemiology of HSV-1 and HSV-2 and implications for serological testing. Herpes 2002; 9: 51–55.
54. Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years–United States, 2005–2008. MMWR Morb Mortal Wkly Rep 2010; 59: 456–459.
55. , Genital herpes simplex virus infections. In: , , , et al., eds. Sexually Transmitted Diseases. New York, NY: McGraw-Hill; 1999: pp. 285–312.
56. , . Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med 1983; 98: 973–983.
57. Cervical cancer: is herpes simplex virus type II a cofactor? Clin Microbiol Rev 1995; 8: 549–556.
58. , , , et al. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G sub-classes. Int J Cancer 1995; 60: 438–442.
59. , , , Effect of herpes simplex virus on the DNA of human papillomavirus 18. J Med Virol 1997; 53: 4–12.
60. , , , et al. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 1990; 17: 90–94.
61. , , , , Clinical and subclinical reactivation of genital herpes virus. Intervirology 2002; 45: 20–23.
62. , , . Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect 2002; 78: 21–25.
63. , , , , . Identification of herpes simplex virus genital infection: comparison of a multiplex PCR assay and traditional viral isolation techniques. Mod Pathol 2001; 14: 152–156.
64. , , . Cytomegalovirus infection of the cervix: morphological observations in five cases of a possibly under-recognised condition. J Clin Pathol 2004; 57: 691–694.
65. , , , A prospective study of maternal cytomegalovirus infection and its effect on the fetus. Am J Obstet Gynecol 1984; 149: 435–440.
66. Pelvic actinomycosis: a review and preliminary look at prevalence. Am J Obstet Gynecol 1999; 180: 265–269.
67. , , Pseudoactinomycotic radiate granules in the lower female genital tract: relationship to the Splendore–Hoeppli phenomenon. Hum Pathol 1982; 13: 898–904.
68. , , . Pemphigus vulgaris: genital involvement. Report of two cases. Obstet Gynecol 1969; 33: 264–266.
69. , . Female genital tuberculosis – a retrospective clinico-pathologic study of 501 cases. Indian J Pathol Microbiol 1993; 36: 389–397.
70. , , , . Necrobiotic granulomas of the uterine cervix. A probable postoperative reaction. Am J Surg Pathol 1984; 8: 841–844.
71. , , . Giant cell arteritis of the female genital tract. A report of three cases. Am J Surg Pathol 1986; 10: 696–701.
72. , , , Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 2000; 39: 71–75.
73. , . Schistosomiasis of the uterine cervix. Br J Obstet Gynaecol 1998; 105: 1329–1331.
74. , . Benign Diseases of the Vulva and Vagina. Boston, MA: GK Hall; 1981.
75. , . Tubal metaplasia of the uterine cervix. Int J Gynecol Pathol 1990; 9: 122–128.
76. , , , . Tubal metaplasia of the uterine cervix: a prevalence study in patients with gynecologic pathologic findings. Int J Gynecol Pathol 1992; 11: 89–95.
77. , , . Tubal and tubo-endometrioid metaplasia of the uterine cervix. Unemphasized features that may cause problems in differential diagnosis: a report of 25 cases. Am J Clin Pathol 1995; 103: 618–623.
78. , , , , . PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma. Am J Surg Pathol 2010; 34: 137–146.
79. . Cone biopsy causes cervical endometriosis and tubo-endometrioid metaplasia. Histopathology 1991; 18: 107–114.
80. , , , et al. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol 2007; 20: 242–247.
81. , . Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia. Int J Gynecol Pathol 1999; 18: 1–4.
82. , , . Transitional cell metaplasia of the uterine cervix and vagina: an underrecognized lesion that may be confused with high-grade dysplasia. A report of 59 cases. Am J Surg Pathol 1997; 21: 510–517.
83. , Transitional (urothelial) cell metaplasia of the uterine cervix: morphological assessment of 31 cases. Int J Gynecol Pathol 1997; 16: 89–98.
84. . Cytologic and histologic diagnosis and significance of controversial squamous lesions of the uterine cervix. Mod Pathol 2000; 13: 252–260.
85. . Traditional cell metaplasia of cervix: a misnomer. Am J Surg Pathol 1998; 22: 774–776.
86. , , , Immunophenotype of transitional metaplasia of the uterine cervix. Int J Gynecol Pathol 1999; 18: 125–129.
87. , , , , . Transitional cell metaplasia of the uterine cervix is related to human papillomavirus: molecular analysis in seven patients with cytohistologic correlation. Cancer 2002; 96: 250–258.
88. . Intestinal metaplasia with argentaffin cells in the uterine cervix. Histopathology 1985; 9: 551–559.
89. , Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia). A correlative study of 23 cases with histologic grading, histochemical analysis of mucins, and immunohistochemical determination of the affinity for four lectins. Cancer 1986; 58: 1272–1280.
90. Arias-Stella reaction of the endocervix: frequency and location. Acta Cytol 1981; 25: 224–228.
91. , . Arias-Stella reaction of the endocervix: a report of 18 cases with emphasis on its varied histology and differential diagnosis. Am J Surg Pathol 2004; 28: 608–612.
92. , , . Microglandular hyperplasia of the cervix: a true “pill” lesion? Int J Gynecol Pathol 1995; 14 50–54.
93. , . Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma. A report of five cases and review of the literature. Am J Surg Pathol 1989; 13: 50–56.
94. , . Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol 1992; 16: 1092–1097.
95. , , , , . Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathol 1997; 16: 52–59.
96. , , . Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 1999; 23: 886–891.
97. , , , , Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 2001; 39: 364–372.
98. , , , et al. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Pathol Res Pract 2013; 209: 173–178.
99. , , , et al. Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study. Br J Cancer 2013; 108: 613–620.
100. , , , et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and ‘adenoma malignum’. Mod Pathol 2004; 17: 962–972.
101. , , . Diffuse laminar endocervical glandular hyperplasia. A benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma). Am J Surg Pathol 1991; 15: 1123–1129.
102. , . Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases. Int J Gynecol Pathol 1995; 14: 293–299.
103. , , , , . CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003; 43: 144–150.
104. , , , . Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ. Int J Gynecol Pathol 1999; 18: 198–205.
105. , , , . Endometriosis with myxoid change. A case simulating pseudomyxoma peritonei. Am J Surg Pathol 1994; 18: 849–853.
106. , . Deep nabothian cysts of the uterine cervix. A possible source of confusion with minimal-deviation adenocarcinoma (adenoma malignum). Int J Gynecol Pathol 1989; 8: 340–348.
107. , , , et al. Gastric mucin is expressed in a subset of endocervical tunnel clusters: type A tunnel clusters of gastric phenotype. Histopathology 2007; 50: 843–850.
108. , . Cystic endocervical tunnel clusters. A clinicopathologic study of 29 cases of so-called adenomatous hyperplasia. Am J Surg Pathol 1990; 14: 895–903.
109. , . Endocervical type A (noncystic) tunnel clusters with cytologic atypia. A report of 14 cases. Am J Surg Pathol 1996; 20: 1312–1318.
110. , , . Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol 1999; 30: 687–694.
111. , , . Placental site nodules and plaques. A clinicopathologic analysis of 20 cases. Am J Surg Pathol 1990; 14: 1001–1009.
112. , Reactive spindle cell nodule of the endocervix simulating uterine sarcoma. Int J Gynecol Pathol 1985; 4: 255–257.
113. , , Inflammatory pseudotumor of the cervix. Int J Gynecol Pathol 1994; 13: 80–86.
114. , , . Ectopic prostatic tissue in the uterine cervix: a report of four cases and review of ectopic prostatic tissue. Am J Surg Pathol 2000; 24: 1224–1230.
115. . Leiomyomas of the uterine cervix: a study of frequency. Int J Gynecol Pathol 1998; 17: 231–234.
116. , , , , . Adenomyomas of the uterine cervix of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected]. Mod Pathol 1996; 9: 220–224.
117. , . Blue nevus of the uterine cervix. Hum Pathol 1985; 16: 79–86.
118. , , , Foci of stromal melanocytes (so-called blue naevus) of the uterine cervix in Japanese women. VirchowsArch A Pathol Anat Histopathol 1991; 418: 327–331.
119. , , , , . Melanosis of the uterine cervix: a report of two cases and discussion of pigmented cervical lesions. Int J Gynecol Pathol 1999; 18: 73–76.
120. . E. Y. S. Gynecologic Cytopathology. Philadelphia, PA: Lippincott-Raven; 1997.
121. , . College of American Pathologists Practical Guide to Gynecologic Cytopathology. Chicago, IL: CAP Press; 2008.
122. , ed. Comprehensive Cytopathology. Philadelphia, PA: Saunders Elsevier; 2008.
123. , ed. The Art and Science of Cytopathology, 2nd edn. Chicago, IL: ASCP Press; 2011.
124. . Diagnostic Cytology of the Uterine Cervix. Baltimore, MD: Williams and Wilkins; 1978.
125. , , . Hormonal effects of Depo-Provera in cervical smears: a comparison with Triphasil and postmenopausal effects. Cancer 2002; 96: 74–82.
126. , . Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997; 314: 228–231.
127. , , , et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197: 346–355.
128. , , , . Glandular cells derived from direct sampling of the lower uterine segment in patients status post-cervical cone biopsy. A diagnostic dilemma. Am J Clin Pathol 1996; 106: 511–516.
129. , , , . Abnormal cervicovaginal smears due to endometriosis: a continuing problem. Diagn Cytopathol 2002; 26: 35–40.
130. , , , , . Reparative changes and the false-positive/false-negative Papanicolaou test: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2001; 125: 134–140.
131. , , . Post-irradiation cytology of cervical cancer patients. Cytopathology 1992; 3: 167–182.
132. , . Significance of cervicovaginal cytology after radiation therapy for cervical carcinoma. Am J Obstet Gynecol 1975; 121: 96–100.
133. , , Cytopathologic changes associated with intrauterine contraceptive devices. A review of cervico-vaginal smears in 350 women. Med J Malaysia 1994; 49: 74–77.
134. , Spectrum of cytologic changes in pregnancy. A review of 100 abnormal cervicovaginal smears, with emphasis on diagnostic pitfalls. Acta Cytol 1995; 39: 905–908.
135. , . Ectopic decidual reaction of the uterine cervix: frequency and cytologic presentation. Acta Cytol 1981; 25: 616–622.
136. , . Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997; 17: 99–107.
137. , , , , . Non-neoplastic findings. In: , , eds. The Bethesda System for Reporting Cervical Cytology, 2nd edn. New York, NY: Springer; 2004.
138. , . Significance of a diagnosis of microorganisms on pap smear. J Low Genit Tract Dis 2008; 12: 40–51.
139. , , , et al. The diagnosis of trichomonas vaginalis in liquid-based Pap tests: morphological characteristics. Diagn Cytopathol 2005; 32: 253–259.
140. , Morphologic criteria associated with Trichomonas vaginalis in liquid-based cytology. Acta Cytol 2010; 54: 582–586.
141. . Cytology: Diagnostic Principles and Clinical Correlates. New York, NY: Saunders; 2003.
142. , , Cervicovaginal flora. Comparison of conventional pap smears and a liquid-based thin-layer preparation. Am J Clin Pathol 2006; 125: 855–859.
143. , , . Candida-related changes and ASCUS: a potential trap! Diagn Cytopathol 1997; 16: 83–86.
144. , . Understanding the bacterial flora of the female genital tract. Clin Infect Dis 2001; 32: e69–77.
145. , , , , . Bacterial vaginosis: comparison of Pap smear and microbiological test results. Mod Pathol 2004; 17: 857–860.
146. , . Diagnosis of vaginitis. Am Fam Phys 2000; 62: 1095–1104.
147. , , , Accuracy of cervical/vaginal cytology in the diagnosis of bacterial vaginosis. Sex Transm Dis 1998; 25: 24–27.
148. IUDs and colonization or infection with Actinomyces. Contraception 2007; 75: S48–50.
149. , , , , The diagnosis of genital herpes – beyond culture: an evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology. Can J Infect Dis Med Microbiol 2007; 18: 233–240.
150. . Chlamydia trachomatis and Female Genital Tact Infection: The Role of Cytology in Diagnosis and Treatment. Cytopathology Annual. Chicago, IL: ASCP Press; 1994.
151. Cytomorphologic and immunocytochemical studies of chlamydial infections in cervical smears. Acta Cytol 1985; 29: 683–691.
152. , , , . Chlamydia trachomatis in routine cervical smears. A microscopic and ultrastructural analysis. Acta Cytol 1993; 37: 343–352.
153. , , , et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002; 51: 1021–1031.
154. , , , et al. Unique cytomegalovirus intracytoplasmic inclusions in ectocervical cells on a cervical/endocervical smear. Diagn Cytopathol 1998; 18: 110–112.
155. , , , , Identification of cytomegalovirus in a liquid-based gynecologic sample using morphology, immunohistochemistry, and DNA real-time PCR detection. Diagn Cytopathol 2004; 30: 411–417.
156. , . Enterobius vermicularis ova in routine cervicovaginal smears. Light and scanning electron microscopic observations. Acta Cytol 1982; 26: 484–487.
157. , , , et al. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg 2005; 72: 311–319.
158. , The changing prevalence of cervical human papilloma virus infection. Aust NZ J Obstet Gynaecol 1990; 30: 375–377.
159. , , , et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000;154: 127–134.
160. , . A study of 10,296 pediatric and adolescent Papanicolaou smear diagnoses in northern New England. Pediatrics 1999; 103: 539–545.
161. , , , et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002; 185: 28–35.
162. , , , , . Cervical cancer screening among low-income women: results of a national screening program, 1991–1995. Obstet Gynecol 1998; 92: 745–752.
163. , , , et al. A case-control study of human papillomavirus and cervical squamous intraepithelial lesions (SIL) in Harris County, Texas: differences among racial/ethnic groups. Cad Saude Publica 1998;14(Suppl 3): 149–159.
164. , , , , . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244–265.
165. , , , et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002; 94: 1406–1414.
166. , , , et al. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer 2002; 98: 435–439.
167. , , , et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346: 1105–1112.
168. , , , et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359: 1093–1101.
169. , , , et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002; 359: 1085–1092.
170. , , , et al. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia. Am J Obstet Gynecol 2002; 186: 28–34.
171. , , , et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283: 1031–1037.
172. , , , et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002; 94: 1604–1613.
173. . Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am 1996; 23: 597–623.
174. , , , et al. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol 1998; 42: 50–58.
175. . Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol 2000; 19: 16–28.
176. , , , et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958–964.
177. , . Human papillomavirus and cervical neoplasia. Cancer Invest 2002; 20: 1080–1085.
178. , , , et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796–802.
179. , , , et al. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study. J Clin Microbiol 2012; 50: 1867–1873.
180. , , , et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106–3114.
181. , , , et al. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev 2011; 20: 287–296.
182. , , , et al. Clinician’s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis 2009; 9: 347–356.
183. . Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol 1995; 6: 109–116.
184. , , , , . Angiogenesis, cell proliferation and apoptosis in progression of cervical neoplasia. Anal Quant Cytol Histol 2002; 24: 103–113.
185. , , . Human papillomavirus: molecular and cytologic/histologic aspects related to cervical intraepithelial neoplasia and carcinoma. Hum Pathol 2008; 39: 154–166.
186. , . Human papillomaviruses. Annu Rev Microbiol 1994; 48: 427–447.
187. , . The genetic program of genital human papillomaviruses in infection and cancer. Obstet Gynecol Clin North Am 1996; 23: 735–758.
188. , , , et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 1993; 90: 3988–3992.
189. , , . Special commentary: patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 2010; 134: 193–199.
190. , , , et al. Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology. J Clin Microbiol 2011; 49: 1071–1076.
191.Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000; 92: 397–402.
192. , . Human papillomavirus testing – are you ready for a new era in cervical cancer screening? Arch Pathol Lab Med 2003; 127: 927–929.
193. , , , et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 2012; 16: 175–204.
194. , . Dysplasia of the uterine cervix. Ann NY Acad Sci 1956; 63: 662–682.
195. . Cervical intraepithelial neoplasia. Pathol Annu 1973; 8: 301–328.
196. , , . Consistency in the histological diagnosis of epithelial abnormalities of the cervix uteri. J Clin Pathol 1968; 21: 67–70.
197. , , , et al. Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3. Aust NZ J Obstet Gynaecol 2010;50: 363–370.
198. , , , et al. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol 1997; 28: 899–904.
199. , , , et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002; 360: 228–229.
200. , , , et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women’s Health Study. J Infect Dis 2002; 186: 462–469.
201. , , , et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79: 328–337.
202. , , , High-risk types of human papillomavirus associated with the progression of cervical dysplasia to carcinoma. J Obstet Gynaecol Res 1999; 25: 281–286.
203. , , , et al. Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 2002; 156: 158–164.
204. . Symposium part 1: should the Bethesda System terminology be used in diagnostic surgical pathology? Point. Int J Gynecol Pathol 2003; 22: 5–12.
205. Symposium part 2: should the Bethesda System terminology be used in diagnostic surgical pathology? Counterpoint. Int J Gynecol Pathol 2003; 22: 13–17.
206. , , , . Morphometric study of intraepithelial neoplasia of the uterine cervix. Obstet Gynecol 1982; 60: 210–214.
207. , , , et al. Topographic study of cervical condyloma and intraepithelial neoplasia. Cancer 1987; 59: 2064–2070.
208. , , , , . Human papillomaviruses and the pathogenesis of cervical neoplasia. A study by in situ hybridization. Cancer 1989; 64: 2104–2110.
209. , , , et al. Localized distribution of human papillomavirus genotypes in the uterine cervix. Eur J Gynaecol Oncol 2002; 23: 203–206.
210. , , , . Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst 1996; 88: 355–358.
211. , , , et al. Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression. Clin Cancer Res 2001; 7: 1306–1312.
212. , , , et al. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett 2000; 154: 189–194.
213. . Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186–192.
214. , , , Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999; 91: 252–258.
215. , , , et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425–434.
216. , . Human papillomavirus DNA in situ hybridization may be used for the quality control of genital tract biopsies. Obstet Gynecol 1990; 75: 223–226.
217. , , , et al. Value of morphological criteria in diagnosing cervical HPV lesions confirmed by in situ hybridization and hybrid capture assay. Pathol Res Pract 2001; 197: 677–682.
218. , , , et al. Virological and biological characteristics of cervical intraepithelial neoplasia grade I with marked koilocytotic atypia. Hum Pathol 1998; 29: 1068–1073.
219. , Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285: 1500–1505.
220. , , , The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report. Am J Clin Pathol 2007; 127: 805–815.
221. , , , et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol 2007; 26: 441–446.
222. , , , et al. Atypical immature metaplasia (AIM). A subset of human papilloma virus infection of the cervix. Cancer 1983; 51: 2214–2219.
223. , , , , Papillary immature metaplasia of the cervix: a distinct subset of exophytic cervical condyloma associated with HPV-6/11 nucleic acids. Mod Pathol 1992; 5: 391–395.
224. , , , et al. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 2010; 34: 1077–1087.
225. , , , et al. Comparative evaluation of nm23 and p16 expression as biomarkers of high-risk human papillomavirus infection and cervical intraepithelial neoplasia 2(+) lesions of the uterine cervix. Histopathology 2010; 57: 580–586.
226. , , , et al. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004; 35: 1477–1483.
227. , , , et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006; 19: 384–391.
228. , , , et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276–284.
229. , , , et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004; 35: 689–696.
230. , , , et al. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol 2010; 63: 972–977.
231. , , , et al. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 2010; 133: 395–406.
232. , , , et al. Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2008; 32: 502–512.
233. , , , et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1389–1399.
234. , , , et al. p16 INK4a immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol 2009; 28: 90–97.
235. . What is the value of proliferation markers in the normal and neoplastic cervix? Histol Histopathol 1998; 13: 249–254.
236. , , , et al. Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection. Int J Gynecol Pathol 2002; 21: 22–26.
237. Utility of MIB-1 in evaluating cauterized cervical cone biopsy margins. Int J Gynecol Pathol 1999; 18: 211–214.
238. , , , , . Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol 1997; 16: 15–21.
239. , , , et al. Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol 2002; 26: 70–75.
240. , , , et al. Evaluation of MIB-1-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1501–1507.
241. , , , et al. Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Am J Clin Pathol 2011; 135: 212–220.
242. , , . Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens. Int J Gynecol Pathol 2010; 29: 79–87.
243. , , , , . Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study. Lupus 2000; 9: 542–544.
244. , , , et al. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol 1984; 150: 300–308.
245. , , , et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986; 68 251–258.
246. , , , et al. Abnormal cervical cytology in bone marrow transplant recipients. Bone Marrow Transpl 2001; 28: 393–397.
247. , , , et al. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus. Gynecol Oncol 2001; 82: 27–31.
248. , , , et al. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. Aids 2000; 14: 1775–1784.
249. , , , et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women’s interagency HIV study. J Acquir Immune Defic Syndr 2001; 27: 432–442.
250. , Improved outcome of cervical neoplasia in HIV-infected women in the era of highly active antiretroviral therapy. AIDS Patient Care STDS 2002; 16: 61–65.
251. United States Cancer Statistics: 1999–2009 Incidence and Mortality Web-based Report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2013.
252. , , , , Clonality analysis of synchronous lesions of cervical carcinoma based on X chromosome inactivation polymorphism, human papillomavirus type 16 genome mutations, and loss of heterozygosity. J Exp Med 2002; 195: 845–854.
253. , , , et al. Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia. Apmis 2001; 109: 607–617.
254. , , , , Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias. Anticancer Res 2001; 21: 1001–1006.
255. , , , , Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. Anticancer Res 1998; 18: 3991–3998.
256. , , , , . K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix. Oncol Rep 2002; 9: 129–133.
257. , , , et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–19.
258. , , , et al. Human papillomavirus DNA in distant metastases of cervical cancer. Gynecol Oncol 1993; 48: 56–60.
259. , , , et al. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr 1996; 17–25.
260. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: 103–104.
261. , , , et al. Protocol for the examination of specimens from patients with carcinoma of the uterine cervix. 2011.
262. Carcinoma of the cervix uteri. In: , , , et al., eds., SGO Handbook: Staging of Gynecologic Malignancies. Chicago, IL: Society of Gynecologic Oncologists; 1994: pp. 15–22.
263. Carcinoma of the cervix uteri. In: , , , et al., eds., SGO Handbook: Staging of Gynecologic Malignancies. Chicago, IL: Society of Gynecologic Oncologists; 1997: pp. 15–20.
264. , , , , Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA). Cancer 1991; 67: 1037–1045.
265. , , , et al. Assessment of the revised International Federation of Gynecology and obstetrics staging for early invasive squamous cervical cancer. Gynecol Oncol 1999; 74: 165–169.
266. , . Stage IA carcinoma of the cervix revisited. Obstet Gynecol 1996; 87: 1052–1059.
267. , , , . Superficially invasive squamous cell carcinoma of the cervix. Obstet Gynecol 1988; 72: 399–403.
268. , , , et al. The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma. Acta Obstet Gynecol Scand 2009; 88: 209–215.
269. , , , et al. Clinical efficacy of conservative laser therapy for early-stage cervical cancer. Int J Gynecol Cancer 2007; 17: 455–459.
270. , , , et al. Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases. Int J Gynecol Cancer 2000; 10: 42–52.
271. , . Micro-invasive squamous cell carcinoma of the cervix: a clinico-pathologic study of 200 cases with long-term follow-up. Int J Gynecol Cancer 1994; 4: 257–264.
272. , , , et al. Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up. Int J Gynecol Cancer 2009; 19: 33–38.
273. , . Is large loop excision of the transformation zone (LLETZ) more accurate than colposcopically directed punch biopsy in the diagnosis of cervical intraepithelial neoplasia? Br J Obstet Gynaecol 1991; 98: 588–591.
274. , , , et al. Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. BMJ 1990; 300: 1690–1693.
275. , , , . The impact of loop diathermy on management of early invasive cervical cancer. Int J Gynecol Cancer 1992; 2: 129–133.
276. , , CIN 3: the role of lesion size in invasion. Br J Obstet Gynaecol 1992; 99: 583–586.
277. , , . Diagnostic conization of the cervix: review of 460 consecutive cases. Obstet Gynecol 1986; 67: 766–770.
278. Cytological early detection of cervical carcinoma: possibilities and limitations. Analysis of failures. J Cancer Res Clin Oncol 1993; 119: 513–521.
279. , , The reliability of preconization diagnostic evaluation in patients with cervical intraepithelial neoplasia and microinvasive carcinoma. Gynecol Oncol 1995; 59: 143–147.
280. , , , , . Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 1985; 153: 164–172.
281. , , , et al. Study of superficially invasive carcinoma of the cervix. Obstet Gynecol 1986; 68: 19–24.
282. , . Minimal cervical cancer: definition and histology. Recent Results Cancer Res 1988; 106: 47–56.
283. , . Microinvasive carcinoma of the cervix. The significance of lymphatic invasion and confluent patterns of stromal growth. Cancer 1975; 36: 180–186.
284. Follow-up study of 232 patients with stage Ia1 and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma). Gynecol Oncol 1989; 33: 265–272.
285. , , , eds. Pathology of the Female Reproductive Tract. London: Churchill Livingstone; 2002.
286. . Studies on 200 cases of early squamous cell carcinoma of the cervix. Int J Gynecol Pathol 1993; 12: 193–207.
287. , , , et al. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 1996; 63: 4–9.
288. , , , et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989; 35: 314–320.
289. , , , et al. Microinvasive carcinoma of the uterine cervix: a clinical–pathologic study. Am J Obstet Gynecol 1979; 133: 64–74.
290. , , , Presentation of cervical cancer. Gynecol Oncol 1991; 42: 48–53.
291. , , . Analytical study of cells in cervical squamous cancer. Lab Invest 1957; 6: 241–250.
292. , . Survival in cervical cancer with respect to cell type. Cancer 1959; 12: 384–388.
293. , . Squamous cell carcinoma of the uterine cervix – a review with emphasis on prognostic factors and unusual variants. Semin Diagn Pathol 1990; 7: 173–189.
294. , , , et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 1992; 69: 1750–1758.
295. . Thrombomodulin expression in transitional cell carcinoma. Am J Clin Pathol 1998; 110: 385–390.
296. , , , Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001; 116: 823–830.
297. , , , , FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecol Oncol Int J Gynaecol Obstet 2000; 70: 209–262.
298. , , , et al. Influence of quantity of lymph–vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol 1998; 68: 220–225.
299. , , , et al. Prognostic factors in surgically treated stage IB–IIB carcinoma of the cervix with negative lymph nodes. Int J Gynecol Cancer 1998; 8: 23–26.
300. , , , , Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol 1999; 74: 245–251.
301. , , , et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 2002; 81: 1144–1151.
302. , , Prognostic factors in cervical cancer. Eur J Obstet Gynecol Reprod Biol 1997; 71: 209–213.
303. , , , et al. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet Gynecol Scand 1999; 78: 452–457.
304. , , , et al. Carcinoma of the cervix: the effect of age on survival. Gynecol Oncol 1980; 10: 188–193.
305. , , , et al. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis. Gynecol Oncol 1992; 44: 123–130.
306. , , , , Prediction of lymph node metastases in patients with early squamous cell carcinoma of the cervix uteri by histopathological grading and flow cytometry. Eur J Cancer 1993; 29A: 337–340.
307. , , , , p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome. Gynecol Oncol 2001; 83: 348–354.
308. , , , et al. The relevance of oncogenes as prognostic markers in cervical cancer. Int J Gynecol Cancer 2002; 12: 465–474.
309. , , , et al. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 2002; 95: 531–539.
310. , , . Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma. Gynecol Oncol 2002; 87: 84–89.
311. , , , Immunohistochemical assay of p53, cyclin D1, c-erbB2, EGFr and Ki-67 proteins in HPV-positive and HPV-negative cervical cancers. Folia Histochem Cytobiol 2002; 40: 37–41.
312. , , , et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 1998; 16: 2613–2619.
313. , , , et al. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up. Anticancer Res 2007; 27: 4491–4494.
314. , . Verrucous carcinoma of the cervix and endometrium. Diagn Gynecol Obstet 1980; 2: 197–203.
315. , Verrucous carcinoma of the cervix with endometrial involvement. Int J Gynecol Pathol 1982; 1: 221–226.
316. , , , , . Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods. Pathol Res Pract 1998; 194: 713–720.
317. , , , . Highly differentiated keratinizing squamous cell cancer of the cervix: a rare, locally aggressive tumor not associated with human papillomavirus or squamous intraepithelial lesions. Am J Surg Pathol 2001; 25: 1310–1315.
318. , , , . Papillary squamous cell carcinoma of the uterine cervix: a clinicopathologic study of nine cases. Int J Gynecol Pathol 1986; 5: 1–10.
319. , , , . Papillary squamotransitional cell carcinoma of the cervix: a report of 32 cases. Am J Surg Pathol 1997; 21: 915–921.
320. , , Mixed papillary transitional cell carcinoma and adenocarcinoma of the uterine cervix: a clinicopathologic study of three cases. Int J Gynecol Pathol 2003; 22: 220–225.
321. , , , Papillary squamous cell carcinoma of the uterine cervix: report of three cases and a review of its classification. Int J Gynecol Pathol 2000; 19: 231–235.
322. , , Transitional cell carcinoma of the uterine cervix. A report of six cases with clinical, histologic and cytologic findings. Acta Cytol 2002; 46: 585–590.
323. , . Transitional cell neoplasms (carcinomas and inverted papillomas) of the uterine cervix. A report of five cases. Am J Surg Pathol 1995; 19: 1138–45.
324. , , Squamous cell carcinoma with sarcoma-like stroma of the female genital tract. Clinicopathologic study of four cases. Cancer 1983; 52: 890–898.
325. , , , et al. Lymphoepithelioma-like carcinoma of the uterine cervix: association with Epstein–Barr virus and human papillomavirus. Cancer 1997; 80: 91–97.
326. , , , Predictive value of DNA cytometry in CIN 1 and 2. Image analysis of 193 cases. Anal Quant Cytol Histol 2000; 22: 333–337.
327. , , , , Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000; 95: 821–827.
328. , , , et al. Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 1999; 80: 1306–3111.
329. , , , et al. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006; 106: 1054–1064.
330. , , , et al. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer. Obstet Gynecol 2010; 116: 76–84.
331. . Squamous epithelial abnormalities. In: College of American Pathologists Practical Guide to Gynecologic Cytopathology Morphology, Management and Molecular Methods. Chicago, IL: CAP Press; 2008.
332. , , . Look-alikes and morphologic spectrum of changes. In: College of American Pathologists Practical Guide to Gynecologic Cytopathology Morphology, Management and Molecular Methods. Chicago, IL: CAP Press; 2008.
333. , , Clinical importance of “low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)” terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature. Gynecol Oncol 2011; 121: 152–156.
334. , , , et al. Interobserver variability in subclassification of squamous intraepithelial lesions: results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 1999; 123: 1079–1084.
335. . Hyperchromatic crowded groups: pitfalls in Pap smear diagnosis. Am J Clin Pathol 2000; 114(Suppl): S36–43.
336. . Litigation cells: definition and observations on a cell type in cervical vaginal smears not addressed by the Bethesda System. Diagn Cytopathol 1994; 11: 213–215.
337. , . High grade squamous cervical lesions following negative Papanicolaou smears: false-negative cervical cytology or rapid progression. Diagn Cytopathol 1995; 12: 135–141.
338. , , , . Use of thin-layer preparations for gynecologic smears with emphasis on the cytomorphology of high-grade intraepithelial lesions and carcinomas. Diagn Cytopathol 1996; 14: 201–211.
339. , , , et al. Atypical squamous cells. In: , , eds. The Bethesda System for Reporting Cervical Cytology. New York, NY: Springer; 2004.
340. , , , From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol 1991; 77: 779–782.
341. , , , , . Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am Fam Phys 2009; 80: 147–155.
342. , Management of cervical cytologic abnormalities. Am Fam Phys 2004; 70: 1905–1916.
343. , , , , . Atypical cervical cytology. Colposcopic follow-up using the Bethesda System. J Reprod Med 1993; 38: 443–447.
344. , , , Using the rate of positive high-risk HPV test results for ASC-US together with the ASC-US/SIL ratio in evaluating the performance of cytopathologists. Am J Clin Pathol 2008; 129: 97–101.
345. , , , , . Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: review of ancillary testing modalities and implications for follow-up. J Low Genit Tract Dis 2010; 14: 206–214.
346. , High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression? Mod Pathol 1992; 5: 337–342.
347. , , , et al. Primary screening with liquid-based cytology in an unscreened population in rural China, with an emphasis on reprocessing unsatisfactory samples. Acta Cytol 2002; 46: 470–474.
348. , . Adenocarcinoma in situ of endocervix. Cancer 1953; 6: 887–897.
349. , . Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986; 124: 1045–1047.
350. , . Early invasive adenocarcinoma of the cervix. Cancer 2000; 89: 1048–1055.
351. , , , et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol 1989; 8: 8–17.
352. , , , , . Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer 1981; 48: 768–773.
353. , , , , An adenocarcinoma in situ of the uterine cervix that developed into invasive adenocarcinoma after 5 years. Gynecol Oncol 1990; 36: 128–133.
354. , . Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol Oncol 1999; 75: 55–61.
355. , , . Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997; 90: 1–6.
356. , , . The anatomic distribution of cervical adenocarcinoma in situ: implications for treatment. Am J Obstet Gynecol 1987; 157: 21–25.
357. , , , . The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Adenocarcinoma in situ. Cancer 1988; 61: 1171–1181.
358. , Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 1986; 39: 22–28.
359. , . Apoptotic bodies: a consistent morphologic feature of endocervical adenocarcinoma in situ. Am J Surg Pathol 1998; 22: 434–439.
360. , , , et al. Proposal of a new scoring scheme for the diagnosis of noninvasive endocervical glandular lesions. Am J Surg Pathol 2003; 27: 452–460.
361. , , , . Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol 2008; 27: 92–100.
362. . Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2002; 21: 314–326.
363. . Adenocarcinoma in situ of the cervix – the margins must be clear. Gynecol Oncol 2000; 79: 4–5.
364. , The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol 1998; 109: 727–732.
365. , , . Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995; 59: 179–182.
366. , , , Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol 2000; 79: 207–210.
367. . Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol 1990; 7: 190–204.
368. , , Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status. Int J Gynecol Pathol 1997; 16: 103–110.
369. , , , , Expanded cytologic criteria for the diagnosis of adenocarcinoma in situ of the cervix and related lesions. Acta Cytol 1980; 24: 283–296.
370. , , , , . High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer 1992; 70: 136–146.
371. , , In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix. Pathology 1991; 23: 85–89.
372. . In-situ and microinvasive adenocarcinoma of the uterine cervix. A clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol 1975; 64: 155–170.
373. . Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. A study by in situ hybridization with biotinylated DNA probes. Cancer 1990; 65: 2588–2593.
374. , , . Endocervical intraepithelial glandular atypia (dysplasia): a histopathologic, human papillomavirus, and MIB-1 analysis of 25 cases. Hum Pathol 2000; 31: 656–664.
375. , , . Endocervical intraepithelial glandular atypia (dysplasia): a histopathologic, human papillomavirus, and MIB-1 analysis of 25 cases. Hum Pathol 2000; 31: 656–664.
376. . Glandular lesions of the uterine cervix. Mod Pathol 2000; 13: 261–274.
377. , Adenocarcinoma in situ and invasive adenocarcinoma of the uterine cervix. An immunohistologic study with antibodies specific for several epithelial markers. Cancer 1984; 54: 103–109.
378. , , , et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol 2002; 33: 899–904.
379. , , , et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003; 27: 187–193.
380. , , , et al. Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1999; 18: 109–114.
381. , , , et al. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol 2007; 26: 71–75.
382. , , . Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl Pathol 1987; 5: 47–56.
383. , , Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol 1997; 89: 88–93.
384. . Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2000; 19: 29–38.
385. , . The relationship of glands to thick-wall blood vessels as a marker of invasion in endocervical adenocarcinoma. Int J Gynecol Pathol 2005; 24: 125–130.
386. , , , et al. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis. Cancer 1985; 56: 167–172.
387. , , , et al. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985; 65: 46–52.
388. , , , et al. Early adenocarcinoma of the uterine cervix. Gynecol Oncol 1997; 65: 281–285.
389. , , , et al. Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up. Int J Gynecol Cancer 2010; 20: 1063–1066.
390. , , , et al. Microinvasive adenocarcinoma of the cervix. Am J Obstet Gynecol 2012; 206: 80.e1–6.
391. , , Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Hlth (Larchmt) 2012; 21: 1031–1037.
392. , , , . The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States – a 24-year population-based study. Gynecol Oncol 2000; 78: 97–105.
393. , , , , . Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer 2000; 89: 1291–1299.
394. Cervical cancer screening in England. Eur J Cancer 2000; 36: 2205–2208.
395. , , , et al. Invasive cervical cancer incidence and mortality among Canadian women aged 15 to 29 and the impact of screening. J Obstet Gynaecol Can 2012; 34: 1167–1176.
396. , , , et al. Epidemiology of cervical cancer by cell type. Cancer Res 1987; 47: 1706–1711.
397. , . Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993; 15: 486–498.
398. , , , et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 2000; 82: 1348–1352.
399. , , , et al. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int J Cancer 1986; 38: 339–344.
400. , , , et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999; 8: 1079–1085.
401. , , , et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000; 77: 149–154.
402. , . Coexistence of ovarian neoplasms and endocervical adenocarcinoma. Obstet Gynecol 1984; 64: 553–556.
403. , . Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix. A clinicopathological analysis of 16 cases. Int J Gynecol Pathol 1988; 7: 99–111.
404. , , , , . Adenocarcinoma and mixed carcinoma of the uterine cervix. I. A clinicopathologic study. Cancer 1982; 49: 2560–2570.
405. , , , et al. Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis. Gynecol Oncol 2011; 121: 135–142.
406. , . Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer 1989; 63: 1773–1779.
407. , , . Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993; 12: 1–7.
408. , , , et al. Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern. Gynecol Oncol 1997; 64: 147–152.
409. , , , A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002; 21: 11–15.
410. , , . Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 2002; 21: 4–10.
411. , , , . Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol 2002; 21: 217–223.
412. , , , et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. VirchowsArch 2003; 442: 271–277.
413. , , , . Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol 2002; 26: 998–1006.
414. , p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003; 22: 231–235.
415. , , , et al. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors. Int J Gynecol Cancer 2013; 23: 380–384.
416. , , , et al. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol 1999; 73: 184–190.
417. , , , Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 1999; 73: 42–46.
418. , , , Mucin production in defining mixed carcinoma of the uterine cervix: a clinicopathologic study. Int J Gynecol Pathol 1985; 4: 314–327.
419. , , , et al. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986; 57: 1584–1593.
420. , , , , Prognostic factors for relapse and pelvic lymph node metastases in early stage I adenocarcinoma of the cervix. Gynecol Oncol 1999; 74: 423–427.
421. , Extremely well-differentiated adenocarcinoma (“adenoma malignum”) of the cervix. Int J Gynecol Pathol 1983; 2: 28–41.
422. , , . Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions. Int J Gynecol Pathol 1984; 3: 261–276.
423. , , , et al. A clinicocytopathologic study of adenoma malignum of the uterine cervix. Gynecol Oncol 1998; 70: 219–223.
424. , , Adenoma malignum of the uterine cervix associated with Peutz–Jeghers syndrome. Int J Gynaecol Obstet 1996; 53: 171–172.
425. , , , et al. Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest 2003; 83: 35–45.
426. , . Minimal-deviation endometrioid adenocarcinoma of the uterine cervix. A report of five cases of a distinctive neoplasm that may be misinterpreted as benign. Am J Surg Pathol 1993; 17: 660–665.
427. , , , , . Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989; 13: 717–729.
428. , , , et al. Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol 1989; 33: 241–247.
429. , . Invasive adenocarcinoma and related tumors of the uterine cervix. Semin Diagn Pathol 1990; 7: 205–227.
430. , , , et al. A comparison of the three most common Papanicolaou smear collection techniques. Obstet Gynecol 1994; 84: 168–173.
431. , , , . Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears. Acta Cytol 1992; 36: 1–10.
432. . Adenocarcinoma of the uterine cervix. An evaluation of the available diagnostic methods. Acta Pathol Microbiol Scand Suppl 1978; 1–59.
433. , , , , . Adenocarcinoma of the cervix: histopathologic and clinical features. Am J Obstet Gynecol 1977; 129: 3043–15.
434. , , , et al. ASCUS and AGUS criteria. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol 1998; 42: 16–24.
435. , , , . Clinical significance of histiocytes in the detection of endometrial adenocarcinoma and hyperplasia. Diagn Cytopathol 1998; 19: 89–93.
436. , , Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Gynecol Oncol 2001; 80: 37–43.
437. , , . Endometrial cells of the “lower uterine segment” (LUS) in cervical smears obtained by endocervical brushings: a source of potential diagnostic pitfall. Diagn Cytopathol 1995; 12: 263–268; discussion 268–271.
438. , . Cytologic detection of endometrial pathology by Pap smears. Diagn Cytopathol 1999; 20: 181–182.
439. , , , , . Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol 1988; 71: 242–244.
440. , , , . Classification of endometrial cells on cervical cytology. Obstet Gynecol 1990; 76: 1000–1005.
441. , , , et al. Atypical glandular cells of undetermined significance. Diagnostic accuracy and interobserver variability using select cytologic criteria. Am J Clin Pathol 1997; 107: 299–307.
442. , , Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn Cytopathol 1995; 13: 202–208.
443. , . Follow-up of abnormal gynecologic cytology: a college of American pathologists Q-probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med 2000; 124: 665–671.
444. , , , . Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006; 107: 701–708.
445. , , . Cytohistologic correlation between AGUS and biopsy-detected lesions in postmenopausal women. Acta Cytol 2000; 44: 41–45.
446. , , , et al. Atypical glandular cells of undetermined significance. Cytologic criteria to separate clinically significant from benign lesions. Am J Clin Pathol 1995;104: 574–582.
447. , . Early endocervical glandular neoplasia. I. Histomorphology and cytomorphology. Acta Cytol 1986; 30: 115–126.
448. , , , , . Endocervical adenocarcinoma in situ: an analysis of cellular features. Diagn Cytopathol 1997; 17: 326–332.
449. Glandular epithelial abnormalities. In College of American Pathologists Practical Guide to Gynecologic Cytopathology Morphology, Management and Molecular Methods. Chicago, IL: CAP Press; 2008.
450. . Adenocarcinoma in situ with a small cell (endometrioid) pattern in cervical smears: a test of the distinction from benign mimics using specific criteria. Cancer 1999; 87: 254–258.
451. , , , , . Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ. Acta Cytol 1999; 43: 74–80.
452. , , , , ThinPrep Pap test. Accuracy for glandular disease. Acta Cytol 1999; 43: 81–85.
453. , Endocervical glandular neoplasia and its mimics in ThinPrep Pap tests. A descriptive study. Acta Cytol 1999; 43: 369–375.
454. , . Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears. Diagn Cytopathol 1997; 16: 168–173.
455. . Atypical glandular cells in cervical smears from women who have undergone cone biopsy. A potential diagnostic pitfall. Acta Cytol 1993; 37: 705–709.
456. , , , et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999; 30: 816–825.
457. , , . The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer 1985; 56: 2256–2263.
458. , , , et al. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. Gynecol Oncol 2007; 107: 458–463.
459. , , , . Glassy cell carcinoma of the cervix. Cytologic and clinicopathologic analysis. Cancer 1983; 52: 307–312.
460. , , , et al. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer 1997; 79: 2229–2236.
461. , , , et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000; 157: 1055–1062.
462. , . Papillary serous adenocarcinoma of the uterine cervix: a report of three cases. Mod Pathol 1992; 5: 426–431.
463. , , Adenoid cystic and adenoid basal carcinoma of the uterine cervix: comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative ‘reserve cell’ origin. Am J Surg Pathol 1999; 23: 448–458.
464. , . Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia. Am J Surg Pathol 1998; 22: 965–975.
465. . Adenoid basal carcinoma of the uterine cervix: evolution of a distinctive clinicopathologic entity. Int J Gynecol Pathol 1997; 16: 299–300.
466. , , Adenoid basal carcinoma of the uterine cervix: detection of integrated human papillomavirus in a rare tumor of putative “reserve cell” origin. Int J Gynecol Pathol 1997; 16: 307–312.
467. , . Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol 1990; 14: 1100–1111.
468. , , , . Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings. Am J Surg Pathol 2001; 25: 379–387.
469. , , , , . Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component. Am J Surg Pathol 1995; 19: 1158–1171.
470. , , , et al. Immunopathological study of mesonephric lesions of cervix uteri and vagina. Eur J Gynaecol Oncol 2003; 24: 154–156.
471. , , , et al. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 2003; 27: 178–186.
472. , , . Microcystic endocervical adenocarcinomas: a report of eight cases. Am J Surg Pathol 2000; 24: 369–374.
473. , , Carcinosarcoma of the uterine cervix: a report of eight cases with immunohistochemical analysis and evaluation of human papillomavirus status. Am J Surg Pathol 2001; 25: 338–347.
474. , , , , . Malignant mixed mullerian tumor (MMMT) of the cervix. Gynecol Oncol 2005; 97: 442–445.
475. , , , , . Detection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases. J Clin Pathol 2002; 55: 108–114.
476. , , , , Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases. Int J Gynecol Pathol 2003; 22: 226–230.
477. , , , . Small-cell undifferentiated carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am J Surg Pathol 1988; 12: 684–698.
478. , , , , . CD56 reactivity in small cell carcinoma of the uterine cervix. Int J Gynecol Pathol 2005; 24: 113–117.
479. , , , . Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer. Am J Surg Pathol 1991; 15: 28–32.
480. , , , . Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol 1991; 4: 586–593.
481. , , , . Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer 1994; 73: 672–677.
482. , , , , . Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 2003; 97: 568–574.
483. , , , et al. Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol 1999; 72: 3–9.